End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.8 CNY | -0.50% |
|
+2.23% | +15.10% |
Jun. 07 | Yuyue Medical Denies Reports of Controller's Involvement in Corruption Probe | MT |
Jun. 06 | Yuyue Medical Owners Prohibited from Leaving China for Alleged Links to Baiyao Corruption Case | MT |
Summary
- The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.10% | 5.5B | D+ | ||
+75.69% | 12.57B | B- | ||
+8.16% | 6.66B | C- | ||
-18.30% | 4.88B | B | ||
+14.96% | 4.1B | - | ||
-20.83% | 3.89B | B- | ||
-27.90% | 2.83B | C | ||
+43.47% | 2.31B | C- | ||
+1.98% | 2.07B | - | ||
+9.75% | 1.97B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 002223 Stock
- Ratings Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.